Because bDMARDs, which have the strongest influence on cellular immunity in patients with RA, differ in their mechanisms of action, we further analyzed their impact on VZV-specific and SEB-reactive T cells. The gene discussed is SETBP1; the disease is rheumatoid arthritis.